On November 18, 2024, PI Opportunities Fund, along with SBI Mutual Fund, sold shares at an average price of ₹700 each on NSE, representing 6.6% of the company’s total outstanding equity.
Invesco Mutual Fund and Kotak Mahindra Mutual Fund each acquired 2.6% of Medplus shares, while Franklin Templeton added 1.3%. Meanwhile, Morgan Stanley Asia purchased the remaining 1.4 lakh shares.
The company posted a consolidated net profit of ₹38.74 crore for the quarter ending September 30, up from ₹14.56 crore last year, driven by higher demand for over-the-counter (OTC) medicines.
The company’s revenue from operations increased by 12% to ₹1,576 crore, driven by a roughly 11% growth in its retail segment.
On November 19, 2024, Medplus Health Services share price closed 2.22% higher at ₹735 on NSE. The stock opened at ₹729 and rose to the day’s high of ₹746.40 during the session today.
Medplus Health Services is a leading player in the pharmaceutical retail sector, offering a wide range of medicines, health products, and wellness solutions. Known for its expansive network of outlets, the company caters to a diverse customer base with quality products and efficient services. Its operations span across multiple regions, emphasising accessibility and affordability in healthcare.
Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. It is based on several secondary sources on the internet and is subject to changes. Please consult an expert before making related decisions.
We're Live on WhatsApp! Join our channel for market insights & updates
Enjoy ₹0 Account Opening Charges
Join our 2 Cr+ happy customers
Get the link to download the App
